期刊文献+

RNAi抑制鼻咽癌细胞表皮生长因子受体表达对细胞生长的影响 被引量:9

Effect of silencing epidermal growth factor receptor expression by RNA interference on the growth of nasopharyngeal carcinoma cell 5-8F
下载PDF
导出
摘要 目的利用RNAi技术抑制鼻咽癌细胞5-8F表皮生长因子受体(EGFR)表达,观察细胞生长变化,探讨EGFR与鼻咽癌发生发展之间的相关性。方法利用体外转录法合成EGFR特异性siRNA,将其瞬时转染5-8F,收集转染后细胞总RNA和蛋白,利用RT-PCR和Westernblot法测定EGFR表达水平的变化,并检测EGFR表达抑制后细胞生长速度和生长周期的变化。结果合成的3对siRNA中,有一对使EGFRmRNA表达下降67.5%,蛋白表达下降77%。EGFR表达抑制后5-8F生长速度减慢,并诱导细胞周期停止在G1期。结论RNAi沉默EGFR表达可抑制鼻咽癌细胞生长,并诱导癌细胞停止在G1期.RNAi可作为探索鼻咽癌发生发展机制和基因治疗的有效工具。 Objective To observe the growth and cell cycle changes ofnasopharyngeal carcinoma cell 5-8F in response to silencing of the expression of epidermal growth factor receptor (EGFR) with RNA interference (RNAi), and explore the possible relationships between EGFR and the occurrence, differentiation and progression of nasopharyngeal carcinoma. Method Tl;lree EGFR-specific small interfering RNAs (siRNAs) were obtained by in vitro transcription and synthesis and were transiently transfected into 5-8F cells. The EGFR expression levels in the transfected cells were detected by reverse transcription (RT) -PCR and Western bloting, respectively. After EGFR expression silencing, the growth and cell cycle changes of the cells were observed. Results EGFR mRNA contents and protein levels decreased by approximately 67.5% and 77%, respectively, after RNAi of 5-8F cells, and the cell proliferation decreased and cell cycle arrest at GI phase occurred in association with EGFR silencing. Conclusion EGFR silencing by RNAi can reduce the proliferation ofnasopharyngeal carcinoma cells and induce cell cycle arrest at G1 phase, which sheds light on the possible use of RNAi for further investigation of the pathogenesis and gene theraov of nasooharvngeal carcinoma.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2006年第1期71-74,共4页 Journal of Southern Medical University
基金 国家高技术研究发展计划(863计划)(2001AA216101 2003AA216011)
关键词 RNA干扰 表皮生长因子受体 鼻咽癌 基因沉默 RNA interference epidermal growth factor receptor nasopharyngeal carcinoma gene silence
  • 相关文献

参考文献3

二级参考文献20

  • 1Mcclelland M,Nucl Acid Res,1994年,22卷,21期,4419页
  • 2Liang P,Science,1992年,257卷,14期,967页
  • 3江希明,肿瘤生物学,1990年,240页
  • 4Wakeling AE. Epidermal growth factor receptor tyrosine kinase inhibitors. Curr Opin Pharm 2002; 2: 382-7.
  • 5Wakeling AE, Guy SP, Woodbum JR, Ashton SE, Curry BJ,Barker AJ, et al. ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Res 2002; 62: 5749-64.
  • 6Elbashir SM, Harborth J, Lendechel W, Yalcin A, Weber K,Tuschl T. Duplexes of 21-nucleotides RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411:494-8.
  • 7Hammond SM, Caudy AA, Hannon GJ. Post transcriptional gene silencing by double stranded RNA. Nat Rev Genet 2001; 2:110-9.
  • 8Elbashir SM, Lendechel W, Tuschl T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 2001;15: 188-200.
  • 9Nagy P, Amdt-Jovin D J, Jovin TM. Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB 1) and induce apoptosis in erbB 1-overexpressing cells. Exp Cell Res 2003; 285: 39-49.
  • 10Tsai CM, Chang KT, Li L, Pemg RP, Yang LY. Interrelationships between cellular nucleotide excision repair, cisplatin cytotoxicity, HER-2/neu gene expression and epidermal growth factor receptor level in non-small cell lung cancer.Jpn J Cancer Res 2000: 91: 213-22.

共引文献42

同被引文献89

引证文献9

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部